Jaan Biotherapeutics
PrivateLast Round
Accelerator
Dec 11, 2025
Total Funding Raised
$3.44M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Jaan Biotherapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was an Accelerator round in December 2025.
Jaan Biotherapeutics is a biotechnology company that develops novel therapies intended for regenerating damaged heart tissue in patients with cardiovascular disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jaan Biotherapeutics Comparables
Compare Jaan Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Heqet Therapeutics | 85% | |
| Medley Therapeutics, Inc. | 77% | |
| Renova Therapeutics | 77% |
For institutional investors. Book with your work email.
Jaan Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 11, 2025 | ||||
| Grant | Oct 6, 2025 | ||||
| Grant | Sep 8, 2020 | ||||
| Grant | Mar 16, 2017 |
For institutional investors. Book with your work email.
Jaan Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Charles River Incubator Program | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 11, 2025
Received funding from Charles River Incubator Program.
- Nov 9, 2025
Monthly visitors grew 100% MoM, reaching 2.9K.
For institutional investors. Book with your work email.
Jaan Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Jaan Biotherapeutics's valuation, stock price, and market status.
Is Jaan Biotherapeutics a public or private company?
Jaan Biotherapeutics is a private company.
What is the current stock price of Jaan Biotherapeutics?
Jaan Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Jaan Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jaan Biotherapeutics worth (valuation)?
Valuation information for Jaan Biotherapeutics is not publicly available.
Can I buy Jaan Biotherapeutics stock?
Jaan Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jaan Biotherapeutics's last funding round?
Jaan Biotherapeutics's most recent funding round was Accelerator on December 11, 2025.
Who are the main investors in Jaan Biotherapeutics?
Key investors in Jaan Biotherapeutics include NIH RADx, National Heart, Lung, and Blood Institute, Charles River Incubator Program.
Will Jaan Biotherapeutics IPO soon?
No public IPO plans have been announced for Jaan Biotherapeutics.
How can I track Jaan Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Jaan Biotherapeutics's shares on secondary markets.